Who is the CEO of Atomo Diagnostics Limited?

The CEO of Atomo Diagnostics Limited is John Michael Kelly.

What industry does Atomo Diagnostics Limited belong to?

Atomo Diagnostics Limited operates in the Medical - Devices industry within the Healthcare sector.

Where is Atomo Diagnostics Limited headquartered?

Atomo Diagnostics Limited is headquartered at 3-5 George St, Leichhardt, NSW, 2040, AU.

What is the IPO date of Atomo Diagnostics Limited?

Atomo Diagnostics Limited went public on April 16, 2020.

How many employees does Atomo Diagnostics Limited have?

The total number of employees at Atomo Diagnostics Limited is disclosed periodically in the company's annual financial reports.

Atomo Diagnostics Limited

AT1.AX•ASX

Healthcare

Medical - Devices

A$0.02

A$0.00(0.00%)

Atomo Diagnostics Limited (AT1.AX) Company Profile & Overview

Explore Atomo Diagnostics Limited’s business operations, leadership, sector classification, and key company facts including IPO date, industry, and contact details.

Atomo Diagnostics Limited (AT1.AX) Company Profile & Overview

Atomo Diagnostics Limited engages in the development and sale of medical devices worldwide. It offers rapid diagnostic test devices for COVID-19, HIV screening, pregnancy test, and respiratory test. The company was incorporated in 2010 and is headquartered in Leichhardt, Australia.

SectorHealthcare

IndustryMedical - Devices

CEOJohn Michael Kelly

Contact Information

https://atomodiagnostics.com

61 2 9099 4750

3-5 George St, Leichhardt, NSW, 2040

Company Facts

IPO DateApr 16, 2020

CountryAU

Actively Trading

Frequently Asked Questions

;